Project Grant S10OD038274
Award Date
5/15/25
Completion Date
5/14/26
Dollars Obligated
$1.1M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $1,035,125 to the Dana-Farber Cancer Institute (DFCI) to acquire a NovaSeq X Plus high-throughput DNA sequencing system manufactured by Illumina. The instrument will be integrated into DFCI's Molecular Biology Core Facilities (MBCF) to expand their genomics capabilities and enable cost-effective and rapid turnaround for whole genome sequencing, whole genome methylation...
The federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,507,500 to the University of Massachusetts Medical School (UMass Medical) to expand the capabilities of third-generation DNA/RNA sequencing technologies. The project aims to generate rapid and cost-effective training libraries to allow for direct detection of common DNA damage and RNA modifications, enabling innovative...
This $639,794 federal grant award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the acquisition of an Illumina NextSeq 2000 next-generation DNA sequencing instrument for the Design, Automation, Manufacturing, and Process (DAMP) Laboratory at Boston University. The new sequencing instrument will enable DAMP Lab researchers to study the genomic sequences of novel molecular tools they are developing, which can lead to improvements in drug design,...
This $900,000 Project Grant, awarded by the National Science Foundation's (NSF) Computer and Information Science and Engineering (CFDA 47.070) program, supports the development of custom hardware accelerators and software solutions to enable pervasive use of genome sequencing in precision healthcare. The three key objectives are: 1) designing domain-specific accelerators for whole genome sequencing and emerging genomics applications, 2) developing point-of-care pathogen detectors using real-time...
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a revolutionary DNA sequencing platform by Xgenomes Corp. The goal is to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual DNA bases, enabling high-density sequencing with greater accuracy and lower costs than existing methods. The $384,418 award will fund a...
The National Institute of Standards and Technology (NIST) awarded a $955,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to HMH Hospitals Corporation in Edison, NJ. The grant establishes a nanopore long-read DNA sequencing capability as a core facility within the HMH Center for Discovery and Innovation. Specific equipment and technologies to be procured include the PromethION high-throughput and GridION medium-throughput sequencing systems, along with...
This $1,234,692 Project Grant award from the National Human Genome Research Institute (NHGRI), under the 93.172 Human Genome Research Federal Grant Program, is supporting the development of a novel biomolecule imaging system called PRECYSE by Evizia Inc. The PRECYSE system leverages high-speed atomic force microscopy (HSAFM) to provide enhanced quality control capabilities for next-generation DNA sequencing library preparation. Key features include sizing DNA samples from 100 base pairs to...
This federal Project Grant award, valued at $215,088.00 and made by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program, supports the development of an innovative "next-generation mass spectrometry-based sequencing (NGMS-SEQ)" method for exhaustive de novo sequencing of all RNA species in a sample. The award aims to 1) further develop the NGMS-SEQ approach to directly identify and sequence every RNA molecule, including...
The National Institutes of Health Office of the Director awarded Thomas Jefferson University a $494,430 Project Grant under the Research Infrastructure Programs federal grant program (CFDA 93.351) for the period of September 1, 2022 through August 31, 2023. The grant funds will support the acquisition of an automated liquid handling platform to increase the sequencing capacity and efficiency of the Sidney Kimmel Cancer Center's fee-for-service Metaomics Shared Resource Core Facility. The new...
Sequegenics LLC received a $251,073 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant supports development of low-cost and scalable methods for creating genomic databases using long-read next-generation DNA sequencing technologies. This aligns with the program's goals of fostering innovation in engineering research. The one-year project period runs from August 1, 2021 through July 31,...